|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||3.75 - 3.95|
|52 Week Range||3.13 - 10.95|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
GNC Holdings (GNC) likely to witness year-over-year decline in revenues owing to weakness in the U.S. & Canada and Manufacturing/Wholesale segments in Q1.
GNC Holdings' (GNC) tie-up with Rapid Nutrition is likely to fuel the company's entry and expansion into the Australian healthcare market.
Vitamin retailer General Nutrition Corp. said Thursday it is planning to expand into Australia in a partnership with Australian health products distributor, Rapid Nutrition. The company said Rapid Nutrition ...
Improvement in profitability and outperformance against the industry can be important characteristics in a stock for some investors. Below, I will assess GNC Holdings Inc’s (NYSE:GNC) track record on aRead More...
GNC Holdings (GNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
March 13 (Reuters) - Harbin Pharmaceutical Group Co Ltd : * SAYS IT BUYS 299,950 PREFERENCE SHARES IN GNC * SAYS CONVERSION PRICE FOR EACH PREFERENCE SHARE SET AT $5.35, CO WILL HOLD 40.1 PERCENT IN GNC ...
GNC Holdings Inc (NYSE:GNC) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
GNC Holdings Inc. shares jumped 5% in Friday premarket trading after the company announced an extended maturity date of term loans to March 2021, a two-year extension. With this amendment, the health and ...
Ailing US vitamin and supplement retailer GNC Holdings Inc has sweetened the terms of a complex amendment to its existing credit agreement to extend a looming March 2019 debt maturity, after early consents from lenders fell short of a required threshold, according to three sources familiar with the transaction. GNC launched the amendment on February 13, offering fees to lenders of its US$1.13bn leveraged loan to push out the maturity by two years to March 2021, in order to buy the company additional time to stage a turnaround. Goldman Sachs is advising on the amendment, while JP Morgan is administrative agent.
Vitamin retailer GNC Holdings has received a $300 million investment from a Chinese pharmaceutical company, a result of its recent mission to explore strategic alternatives.
Q4 2017 GNC Holdings Inc Earnings and China Joint Venture with Harbin Pharmaceutical Conference Call
GNC Holdings Inc (NYSE:GNC) has had a great year so far. After losing nearly half of its value in 2017, GNC stock has made a major comeback during the first few weeks of 2018, pushing its share price up more than 20% higher since January 1. The uptick isn’t unfounded either, GNC appears to have found a way out of its precarious, and some would say dire, financial situation.
GNC Holdings Inc (NYSE:GNC), a US$350.41M small-cap, operates in the retail industry impacted by the digital transformation for all retail channels. Physical store retailers faced the inevitable challenge of buildingRead More...
Feb 14 (Reuters) - Harbin Pharmaceutical Group Co Ltd : * SAYS CONTROLLING SHAREHOLDER SIGNS AGREEMENT TO BUY GNC HOLDINGS' CONVERTIBLE PREFERENCE SHARES WORTH $299.95 MILLION * SAYS IT SCRAPS PLAN FOR ...
Stocks that moved substantially or traded heavily on Tuesday: AmerisourceBergen Corp., up $8.32 to $97.77 The Wall Street Journal said Walgreens Boots Alliance is interested in buying the rest of the prescription ...
GNC stock rebounded in January following a favorable fourth-quarter sales preview, and recently bounced again on news of a deal to expand its operations in China.
Shares of GNC are up today thanks to a narrowing bottom-line loss and $300 million investment from a Chinese pharmaceutical company.
The new deal that has GNC stock flying high today includes a $300 million investment into the company by Harbin Pharmaceutical. This will make the Chinese company the single largest shareholder of GNC stock. GNC Holdings Inc and Harbin Pharmaceutical will also be teaming up on a new joint venture.